Public Health
US will spend $1 billion studying long COVID
The U.S. is dedicating $1.15 billion to studying long COVID, a condition in which survivors experience long-term effects of COVID-19.
New test can show if you’ve had COVID-19, even if antibodies fade
The FDA has approved a T cell test for COVID, a first-of-its-kind assay that looks to the immune system’s memory.
Can RNA create a malaria vaccine?
An effective malaria vaccine could save hundreds of thousands of lives each year. Can RNA vaccines like the ones fighting SARs-CoV-2 tackle another disease?
Smartphones can track your blood sugar levels
The ability to easily monitor blood sugar levels would allow everyone to have more control over their own metabolic health — not just people with diabetes.
Cone snail venom may help treat malaria
Clumps of infected red blood cells can make malaria dangerous even after its parasite is treated. Cone snail venom may one day help.
A new bird flu is infecting people. Here’s what we know.
The H5N8 bird flu virus has reportedly infected seven poultry farm workers in Russia. Here’s what we know about the new avian flu threat.
FDA: One-shot COVID-19 vaccine is safe and effective
FDA experts confirm that Johnson and Johnson’s one-shot COVID-19 vaccine is safe and effective, putting it a step closer to authorization.
World’s first COVID-19 human challenge study is a go
Researchers have gotten the green light to deliberately infect people with the coronavirus as part of the world’s first COVID-19 human challenge study.
The hunt for a universal coronavirus vaccine
A universal coronavirus vaccine that protects against multiple coronaviruses could stop the next potential pandemic from ever starting.
Study: Strong immunity without Pfizer vaccine’s second dose
The Pfizer vaccine's second dose might not be as necessary as thought — and ultra-cold storage of the COVID-19 vaccine might not be necessary at all.